Differential modulation of interleukin-2- and interleukin-4-mediated early activation of normal human b lymphocytes by the caspase inhibitor zVAD-fmk

European Cytokine Network

Volumn 13, Issue 4, 2002, Pages 439-445

  Mouhamad, Shahul ^a   Arnoult, Damien ^b   Auffredou, Marie Thérèse ^a   Estaquier, Jérome ^b   Vazquez, Aimé ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

B lymphocyte; Caspase; Cell cycle entry; IL 2; IL 4; Proliferation

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLIN D2; INTERLEUKIN 2; INTERLEUKIN 4; MITOGENIC AGENT; MONOCLONAL ANTIBODY; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; LYMPHOMA CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

AMINO ACID CHLOROMETHYL KETONES; B-LYMPHOCYTES; CASPASES; CELL DIVISION; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; HUMANS; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MITOGENS; RECOMBINANT PROTEINS; STAPHYLOCOCCUS AUREUS;

EID: 0036824646     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Miossec C, Dutilleul V, Fassy F, Diu-Hercend A. 1997. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol. Chem. 272: 13459.
2. Alam A, Cohen LY, Aouad S, Sekaly RP. 1999. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190: 1879.
3. Kennedy NJ, Kataoka T, Tschopp J, Budd RC. 1999. Caspase activation is required for T cell proliferation. J. Exp. Med. 190: 1891.
4. Alnemri ES. 1997. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases (Review). J. Cell Biochem. 64: 33.
5. Cohen GM. 1997. Caspases: the executioners of apoptosis (Review). Biochem. J. 326: 1.
6. Kumar S. 1999. Mechanisms mediating caspase activation in cell death (Review). Cell Death Differ. 6: 1060.
7. Qin H, Srinivasula SM, Wu G, Fernandes-Alnemri T, Alnemri ES, Shi Y. 1999. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399: 549.
8. Schrantz N, Auffredou MT, Bourgeade MF, Besnault L, Leca G, Vazquez A. 2001. Zinc-mediated regulation of caspases activity: dose-dependent inhibition or activation of caspase-3 in the human Burkitt lymphoma B cells (Ramos). Cell Death Differ. 8: 152.
9. Besnault L, Schrantz N, Auffredou MT, Leca G, Bourgeade MF, Vazquez A. 2001. B cell receptor cross-linking triggers a caspase-8-dependent apoptotic pathway that is independent of the death effector domain of Fas-associated death domain protein. J. Immunol. 167: 733.
10. Schrantz N, Bourgeade MF, Mouhamad S, Leca G, Sharma S, Vazquez A. 2001. p38-mediated regulation of an Fas-associated death domain protein-independent pathway leading to caspase-8 activation during TGFbeta-induced apoptosis in human Burkitt lymphoma B cells BL41. Mol. Biol. Cell 12: 3139.
11. Newton K, Harris AW, Bath ML, Smith KG, Strasser A. 1998. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO. y. 17: 706.
12. Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, Hedrick SM. 1998. A role for FADD in T cell activation and development. Immunity 8: 439.
13. Zhang J, Cado D, Chen A, Kabra NH, Winoto A. 1998. Fasmediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392: 296.
14. Schrantz N, Beney GE, Auffredou MT, Bourgeade MF, Leca G, Vazquez A. 2000. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation. J. Immunol. 165: 4346.
15. Blanchard DA, Affredou MT, Vazquez A. 1997. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation. J. Immunol. 158: 3054.
16. Vazquez A, Gerard JP, Olive D, Auffredou MT, Dugas B, Karray S, Delfraissy JF, Galanaud P. 1986. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF). Eur. J. Immunol. 16: 1503.
17. Blanchard DA, Mouhamad S, Auffredou MT, Pesty A, Bertoglio J, Leca G, Vazquez A. 2000. Cdk2 associates with MAP kinase in vivo and its nuclear translocation is dependent on MAP kinase activation in IL-2-dependent Kit 225 T lymphocytes. Oncogene 19: 4184.
18. Tan X, Martin SJ, Green DR, Wang JY. 1997. Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J. Biol. Chem. 272: 9613.
19. Schrantz N, Blanchard DA, Auffredou MT, Sharma S, Leca G, Vazquez A. 1999. Role of caspases and possible involvement of retinoblastoma protein during TGFbeta-mediated apoptosis of human B lymphocytes. Oncogene 18: 3511.
20. Gervais JL, Seth P, Zhang H. 1998. Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damageinduced apoptosis. J. Biol. Chem. 273: 19207.
21. Reuther JY, Baldwin AS, Jr. 1999. Apoptosis promotes a caspase-induced amino-terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB. J. Biol. Chem. 274: 20664.
22. Stroh C, Schulze-Osthoff K. 1998. Death by a thousand cuts: an ever increasing list of caspase substrates (Review). Cell Death Differ. 5: 997.
23. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284.
24. Klemsz MJ, Justement LB, Palmer E, Cambier JC. 1989. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands. J. Immunol. 143: 1032.
25. Bonnefoy JY, Defrance T, Peronne C, Menetrier C, Rousset F, Pene J, De Vries JE, Banchereau J. 1988. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines. Eur. J. Immunol. 18: 117.